Status in Israel
Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Prolonged-Release Tablets 30 X 0.4 mg |
|
Dosage
Adults aged 18 years and older: 1 tablet daily, independently of food. The tablet must be swallowed whole and not be crunched or chewed.
Indications
Lower urinary tract symptoms ( LUTS) associated with benign prostatic hyperplasia (BPH).
Contra-Indications
Hypersensitivity to the active substance or to any of the excipients. History of orthostatic hypotension. Severe hepatic insufficiency.
Special Precautions
Please refer to license holder for full details.
Side Effects
Please refer to license holder for full details.
Drug interactions
Please refer to license holder for full details.
Pregnancy and Lactation
Please refer to license holder for full details.
Overdose
Please refer to license holder for full details.
Important notes
Please refer to license holder for full details.
Manufacturer
Teva Pharmaceutical Industries Ltd, Israel
Licence holder
